Therapy Trends: Multiple Sclerosis -- KOL Insight and Consensus Outlook Modules | Market Research Reports | 2016 : Market Databook || Road Infrastructure Construction in Mexico to 2016 | announces, a new market research report is available in its vast collection:

Therapy Trends: Multiple Sclerosis -- KOL Insight and Consensus Outlook Modules

Charting the Future Multiple Sclerosis Market Landscape

Over the next five years, the global multiple sclerosis (MS) market is set to grow from $12.3 billion in 2011 to $17.3 billion in 2016. Primary drivers of this growth will be the entry of new pipeline therapies, satisfying the unmet needs of convenient administration and more efficacious therapy, and continued uptake of existing therapies.

Therapy Trends Consensus Outlook: Multiple Sclerosis analyses the global MS market players and products of today and tomorrow. Start mapping your market parameters with access to the following comprehensive resources:

An in-depth 5-year forecast report based on analyst consensus, mapping the impact of future events to predicted product performance
A detailed forecast data analysis spreadsheet model comparing critical market parameters including
Timely event-driven market forecast report and data analysis updates over the next 12 months

Mapping Future Events to Product Sales Forecasts

The forecast analysis report component of Consensus Outlook: Multiple Sclerosis delivers a rich analysis of product-level sales forecast data and of the future events that underpin the forecasts. The product of meticulous FirstWord research, its historical sales data (2006–11) is based on company information, and the five-year (2012-16) product level sales forecasts are consensus projections derived from a comprehensive selection of continually assessed equity research reports.

The report combines independent, unbiased, accurate forecasts with invaluable insights into factors that impact future product performance, backed-up by research of analysts who have an unrivalled level of intimacy with the market, the players, their products and their strategies.

Report features:

Historical MS sales from 2006–2011
Forecast MS sales from 2012-2016
Key competitors and drug developers
Predicted product positioning
Current and late-stage pipeline drugs
Future event mapping to forecast data points
Comparative clinical trial results

Interactive Product and Market Forecast Data Model
FirstWord’s MS forecast data model allows to you examine detailed Excel spreadsheets to quickly compare various market parameters.

Market size
Product sales
Company forecasts
Company, brand, and drug class
Mechanism of action
Future events

Forecasts and Analysis Updated Within Days of Major Market Events

Stay a step ahead with Therapy Trends Consensus Outlook updates. Over the next 12 months, you will receive updated market analysis and forecast reports each time a major market event breaks. Updates will be delivered straight into your inbox within days of each event’s occurrence.

Whether it’s a predicted product approval or an unexpected late stage failure, Therapy Trends has the resources and knowledge to keep you up to date with the latest market analysis.

Understand the Unique Benefits of Consensus Outlook

Evaluate future sales forecasts and predicted market growth
Map your market parameters and chart commercial prospects
Assess market share by company and product
Tailor your strategic and investment focus based on the competition
Set proactive launch and branding strategies
Keep up with event-driven market data updates

More Related Reports :

  Charting the Biosimilar and Biobetter Development Pipeline

  FirstImpact: FDA approval of Aubagio

  Consensus Outlook: Multiple Sclerosis

  Therapy Trends: Multiple Sclerosis -- KOL Insight and Consensus Outlook Modules

  Pharma's Future Role in CME

  Therapy Trends: Rheumatoid Arthritis -- Consensus Outlook Module

  Therapy Trends: Rheumatoid Arthritis -- KOL Insight and Consensus Outlook Modules

  Therapy Trends: Rheumatoid Arthritis -- KOL Insight Module

  Pharma Reputations: Managing Perceptions

  Pharma sales force shape, size and structure — where next?

  Sampling: A key business driver in a multi-channel environment

  Inside China’s Healthcare Reforms: Opportunities for Multinational Pharma

  Effective Sales and Marketing Strategies for Orphan Drugs

  New Product Penetration: Understanding & Accelerating New Product Uptake

RSS Link ...

For More details about above & other Reports plz contact :


Contact: Marketing team




You can also request for sample page of above mention reports on